Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Bischler Napieralski Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105859719A details high-yield synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN115073373A details a high-yield asymmetric synthesis route for (R)-5'-methoxylaudanosine, eliminating genotoxic impurities and reducing costs for muscle relaxant manufacturing.
Novel modular route for (-)-eburnamonine via Bischler-Napieralski cyclization offers scalable production for vasodilator API manufacturing.
Patent CN110845410B reveals a safe one-pot method for 6,7-dimethoxy-3,4-dihydroisoquinoline HCl using phosphotungstic acid, offering high purity and cost reduction.
Patent CN102399166B enables high-purity THPBs synthesis. Reduces cost and improves supply chain reliability for neurological drug intermediates.
Novel synthesis route for tetrahydroprotoberberine compounds via Bischler-Napieralski reaction. Enables batch production of l-SPD and d-SPD with high optical purity.